Loeb and Stork offer pointers for beginners and current users alike.
In this video, Stacy Loeb, MD, MSc, and Brian R. Stork, MD, discuss physician social media use, covering topics such as advice for medical professionals just starting out on Twitter, how the platform can enhance scientific conference experiences, and how it can be used to aid in research. Loeb is Professor of Urology and Population Health at New York University and the Manhattan Veterans Affairs. She also hosts the Men's Health Show on Sirius XM satellite radio, and is the incoming Chair of the American Urological Association Public Media Committee. You can find her on Twitter @LoebStacy. Stork is Assistant Clinical Professor in the Department of Urology at the University of Michigan. He is also the current Chairperson for the Urology Care Foundation Public Education Council. He is active on Twitter @StorkBrian and has a long running blog on his website www.Dr.BrianStork.com
Dr. Lacouture on managing dermatological adverse events with apalutamide in prostate cancer
February 7th 2022To investigate the severity and prevalence of dermatologic adverse events associated with apalutamide, Mario E. Lacouture, MD, and investigators conducted a study that will help to manage and counsel patients with prostate cancer in the future, especially with the expanded approval of apalutamide in this space.
How appropriate use criteria for PSMA-PET imaging optimize patient care
February 2nd 2022In a recent interview, Hossein Jadvar, MD, PhD, discussed what the appropriate use criteria consist of for prostate-specific membrane antigen (PSMA)-PET imaging, and why these criteria are vital in ensuring the individualized care of patients.
Dr. Padmanabhan discusses impact of COVID-19
June 11th 2020Urology Times® Editorial Council Member Priya Padmanabhan, MD, MPH, professor of urology at Oakland University William Beaumont School of Medicine, Royal Oak, Michigan, discusses how she has been affected by the coronavirus disease 2019 (COVID-19) pandemic.
Dr. Lacouture on managing dermatological adverse events with apalutamide in prostate cancer
February 7th 2022To investigate the severity and prevalence of dermatologic adverse events associated with apalutamide, Mario E. Lacouture, MD, and investigators conducted a study that will help to manage and counsel patients with prostate cancer in the future, especially with the expanded approval of apalutamide in this space.
How appropriate use criteria for PSMA-PET imaging optimize patient care
February 2nd 2022In a recent interview, Hossein Jadvar, MD, PhD, discussed what the appropriate use criteria consist of for prostate-specific membrane antigen (PSMA)-PET imaging, and why these criteria are vital in ensuring the individualized care of patients.
Dr. Padmanabhan discusses impact of COVID-19
June 11th 2020Urology Times® Editorial Council Member Priya Padmanabhan, MD, MPH, professor of urology at Oakland University William Beaumont School of Medicine, Royal Oak, Michigan, discusses how she has been affected by the coronavirus disease 2019 (COVID-19) pandemic.
2 Commerce Drive
Cranbury, NJ 08512